Episode
Episode 472: Is There Any Role for Niacin Therapy?
- Published
- Dec 16, 2025
- Duration seconds
- 1965
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/heart-doc-vip-with-dr-joel-kahn-327754/episodes/episode-472-is-there-any-role-for-niacin-therapy/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/heart-doc-vip-with-dr-joel-kahn-327754/episode-472-is-there-any-role-for-niacin-therapy.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week on Heart Doc VIP , Dr. Joel Kahn takes a fresh look at niacin (vitamin B3) therapy and its role in managing cholesterol and Lipoprotein(a). He reviews both classic and recent research, explains why many clinicians have moved away from niacin, and then walks through data that suggest it may still have value when used thoughtfully and selectively. Dr. Kahn also shares a real-world case study highlighting how niacin can be effective when carefully monitored. In the episode's shorter segments, Dr. Kahn covers a wide range of timely topics, including the relationship between orange juice and heart disease, the link between uterine fibroids and cardiovascular risk, and why achieving remission from pre-diabetes matters more than ever. He also explores research on polyphenol-rich Tartary buckwheat and its potential connection to slower aging, as well as new findings on statin use and muscle strength. As always, the episode blends evidence-based medicine with practical insights you can apply to your own heart-health journey. Sponsor: Thanks to koyah.com/KAHN10 — check out their excellent product line and save with the code KAHN10 .